The obscure advisory committees at the heart of the U.S. drug pricing debate - Trendy News

it is a multi-purpose news source based blog where you will find different news from different fields

Tuesday, April 30, 2019

The obscure advisory committees at the heart of the U.S. drug pricing debate

Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries.


from Reuters: U.S. https://reut.rs/2VwZsGQ

No comments:

Post a Comment